Immune cell tracking could sharpen lyme disease diagnosis

NCT ID NCT07703787

Not yet recruiting Knowledge-focused Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study explores a new way to diagnose Lyme disease by measuring immune cell responses to the bacteria. Researchers use a technique called flow cytometry to analyze T-cells from patients with a late-stage form of Lyme disease. The goal is to see if this method can tell active infection apart from past exposure better than standard antibody tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this approach could provide a more reliable way to diagnose active Lyme infection and predict disease progression.
What could go wrong: This is a small, early-stage observational study. The method may not prove accurate enough for clinical use, and results may not apply to all Lyme disease patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACRODERMATITIS CHRONICA ATROPHICANS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acrodermatitis chronica atrophicans Lyme disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LYME BORRELIOSIS LYME DISEASE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hôpitaux Universitaires de Strasbourg

Strasbourg, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.